Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Clinical trial NCT03367871 · TERMINATED

Trial details

NCT number: NCT03367871
Sponsor: University of Miami
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2018-09-06
Primary completion: 2023-01-30
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.